TERMIUM Plus^®

Record 1,  Textual support,  English

Record number: 1, Textual support number: 1 DEF

A SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] variant with genetic changes that are suspected to affect virus characteristics with some indication that it may pose a future risk, but evidence of phenotypic or epidemiological impact is currently unclear, requiring enhanced monitoring and repeat assessment pending new evidence.  1, record 1, English, - variant%20under%20monitoring

Record 1,  Textual support,  French

Record number: 1, Textual support number: 1 DEF

Variant du SARS-CoV-2 [coronavirus 2 du syndrome respiratoire aigu sévère] qui présente des modifications génétiques soupçonnées d’affecter les caractéristiques du virus, certains éléments indiquant qu'il peut poser un risque futur sans que les preuves de répercussions phénotypiques ou épidémiologiques ne soient claires à l'heure actuelle, et qui doit donc faire l'objet d’une surveillance renforcée et d’une évaluation répétée en attendant de nouvelles preuves.  1, record 1, French, - variant%20sous%20surveillance

Record 1,  Textual support,  Spanish

Record number: 1, Textual support number: 1 CONT

Realizar investigaciones de campo para mejorar la comprensión de las características de la variante bajo vigilancia en la epidemiología de la COVID-19 (infectividad, neutralización, gravedad, etc.)  1, record 1, Spanish, - variante%20bajo%20vigilancia

Record 2,  Textual support,  English

Record number: 2, Textual support number: 1 CONT

A SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] isolate is a variant of interest (VOI) if, compared to a reference isolate, its genome has mutations with established or suspected phenotypic implications, and either: has been identified to cause community transmission/multiple COVID-19 cases/clusters, or has been detected in multiple countries; or is otherwise assessed to be a VOI by WHO [World Health Organization] in consultation with the WHO SARS-CoV-2 Virus Evolution Working Group.  3, record 2, English, - variant%20of%20interest

Record number: 2, Textual support number: 1 OBS

variant under investigation; VUI: designations used by Public Health England.  4, record 2, English, - variant%20of%20interest

Record 2,  Textual support,  French

Record number: 2, Textual support number: 1 DEF

Variant ayant un impact épidémiologique ou clinique potentiel(s), qui est sous surveillance.  3, record 2, French, - variant%20d%26rsquo%3Bint%C3%A9r%C3%AAt

Record number: 2, Textual support number: 1 CONT

Un isolat du SARS-CoV-2 est un variant à suivre si, par rapport à un isolat de référence, son génome présente des mutations ayant des implications phénotypiques établies ou présumées, et : si on sait qu'il est à l'origine d’une transmission communautaire/de plusieurs cas/d’un groupe de cas de COVID-19, ou qu'il a été détecté dans plusieurs pays; ou s’il est considéré, pour d’autres raisons, comme un variant à suivre par l'OMS [Organisation mondiale de la Santé], en consultation avec le Groupe de travail de l'OMS sur l'évolution du virus SARS-CoV-2.  2, record 2, French, - variant%20d%26rsquo%3Bint%C3%A9r%C3%AAt

Record number: 2, Textual support number: 1 OBS

variant d’intérêt : désignation en usage au gouvernement du Canada et à l’Institut national de santé publique du Québec.  4, record 2, French, - variant%20d%26rsquo%3Bint%C3%A9r%C3%AAt

Record number: 2, Textual support number: 2 OBS

variant à suivre : désignation en usage à l’Organisation mondiale de la Santé.  4, record 2, French, - variant%20d%26rsquo%3Bint%C3%A9r%C3%AAt

Record 2,  Textual support,  Spanish

Record number: 2, Textual support number: 1 CONT

Una variante de interés se convierte en una variante de preocupación si hay constancia de que se propaga más fácilmente, causa una enfermedad más grave, escapa a la respuesta inmunitaria del organismo, cambia los síntomas del virus o disminuye la eficacia de las herramientas conocidas, como las medidas de salud pública, los diagnósticos, los tratamientos y las vacunas.  1, record 2, Spanish, - variante%20de%20inter%C3%A9s

Record number: 2, Textual support number: 2 CONT

Se considera que una variante es de interés (VOI, por sus siglas en inglés) si hay evidencia científica inicial de mutaciones que se sospecha causen cambios significativos, y está circulando ampliamente (por ejemplo, se sabe que ha infectado muchos grupos de personas, o se ha detectado en varios países).  1, record 2, Spanish, - variante%20de%20inter%C3%A9s

Record 3,  Textual support,  English

Record number: 3, Textual support number: 1 DEF

The virus that causes COVID-19.  5, record 3, English, - severe%20acute%20respiratory%20syndrome%20coronavirus%202

Record number: 3, Textual support number: 1 CONT

In late December 2019, patients presenting with viral pneumonia due to an unidentified microbial agent were reported in Wuhan, China. A novel coronavirus was subsequently identified as the causative pathogen, provisionally named 2019 novel coronavirus (2019-nCoV).  6, record 3, English, - severe%20acute%20respiratory%20syndrome%20coronavirus%202

Record number: 3, Textual support number: 1 OBS

severe acute respiratory syndrome coronavirus 2; SARS-CoV-2: [designations] assigned by the Coronavirus Study Group of the International Committee on Taxonomy of Viruses (ICTV).  5, record 3, English, - severe%20acute%20respiratory%20syndrome%20coronavirus%202

Record 3,  Textual support,  French

Record number: 3, Textual support number: 1 DEF

Virus responsable de la COVID-19.  7, record 3, French, - coronavirus%202%20du%20syndrome%20respiratoire%20aigu%20s%C3%A9v%C3%A8re

Record number: 3, Textual support number: 1 OBS

coronavirus 2 du syndrome respiratoire aigu sévère; SARS-CoV-2 :[désignations] retenues par le Comité international de taxonomie des virus(ICTV) et par l'Organisation mondiale de la Santé(OMS).  7, record 3, French, - coronavirus%202%20du%20syndrome%20respiratoire%20aigu%20s%C3%A9v%C3%A8re

Record number: 3, Textual support number: 2 OBS

SARS-CoV-2 :[Sigle] à privilégier pour faciliter l'accès à l'information et diminuer les risques de confusion dans les communications à l'échelle internationale.  7, record 3, French, - coronavirus%202%20du%20syndrome%20respiratoire%20aigu%20s%C3%A9v%C3%A8re

Record 3,  Textual support,  Spanish

Record 4,  Textual support,  English

Record number: 4, Textual support number: 1 OBS

The Canadian COVID-19 Genomics Network (CanCOGeN) was created to coordinate and fund SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2], the virus that causes COVID-19 disease, and host (human) genome sequencing efforts and support the sharing of resultant data.  3, record 4, English, - Canadian%20COVID%2D19%20Genomics%20Network

Record 4,  Textual support,  French

Record number: 4, Textual support number: 1 OBS

Le Réseau canadien de génomique COVID-19 [...] a été créé pour coordonner et financer les efforts de séquençage du SARS-CoV-2 [coronavirus 2 du syndrome respiratoire aigu sévère], le virus à l'origine de la maladie à coronavirus(COVID-19), et du génome hôte(humain), ainsi qu'appuyer le partage des données qui en résultent.  3, record 4, French, - R%C3%A9seau%20canadien%20de%20g%C3%A9nomique%20COVID%2D19

Record 4,  Textual support,  Spanish

Record 5,  Textual support,  English

Record number: 5, Textual support number: 1 DEF

An acute viral disease caused by SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2].  4, record 5, English, - COVID%2D19

Record number: 5, Textual support number: 1 CONT

[On February 11, 2020], the World Health Organization (WHO) declared an official name for the new coronavirus disease: COVID-19 ...  5, record 5, English, - COVID%2D19

Record number: 5, Textual support number: 2 CONT

Some people infected with the virus have no symptoms. When the virus does cause symptoms, common ones include fever, body ache, dry cough, fatigue, chills, headache, sore throat, loss of appetite, and loss of smell. In some people, COVID-19 causes more severe symptoms like high fever, severe cough, and shortness of breath, which often indicates pneumonia. People with COVID-19 are also experiencing neurological symptoms, gastrointestinal (GI) symptoms, or both. These may occur with or without respiratory symptoms.  6, record 5, English, - COVID%2D19

Record number: 5, Textual support number: 1 OBS

COVID-19: The term "COVID-19" was formed using elements of the words coronavirus, disease and 2019.  4, record 5, English, - COVID%2D19

Record 5,  Textual support,  French

Record number: 5, Textual support number: 1 DEF

Maladie virale aiguë causée par le SARS-CoV-2 [coronavirus 2 du syndrome respiratoire aigu sévère].  3, record 5, French, - COVID%2D19

Record number: 5, Textual support number: 1 OBS

COVID-19 : Le terme «COVID-19» est de genre féminin, étant donné que le «D» de «COVID» désigne le mot de base «disease» («maladie» en français).  3, record 5, French, - COVID%2D19

Record 5,  Textual support,  Spanish

Record number: 5, Textual support number: 1 OBS

COVID-19; covid-19; Covid-19: La Fundación del Español Urgente (Fundéu BBVA), con el asesoramiento de la Real Academia Española, indica que la Organización Mundial de la Salud ha decidido llamar "COVID-19" (acrónimo del inglés "coronavirus disease") a la enfermedad causada por el coronavirus [del síndrome respiratorio agudo severo], y escribe esta denominación con mayúsculas y con un guion antes de los dos dígitos […] Hay que destacar que esta identificación se aplica a la enfermedad, no al virus […] No obstante, si en un texto general se desea lexicalizar esta denominación pasándola a minúsculas, lo adecuado es no dejar la inicial mayúscula porque se trata de un nombre común de enfermedad: "covid-19". El guion forma parte del nombre establecido […] En cambio, no es adecuada la grafía "Covid-19", en la que se mantiene la mayúscula inicial como si se tratara de un nombre propio.  2, record 5, Spanish, - COVID%2D19

Record number: 5, Textual support number: 2 OBS

COVID-19; COVID; covid: La Fundación del Español Urgente (Fundéu BBVA), con el asesoramiento de la Real Academia Española, indica que cabe la posibilidad de emplear […] expresiones descriptivas como "enfermedad del coronavirus" o "neumonía por coronavirus". En estos casos, puesto que no se está indicando de qué coronavirus se trata, es posible añadir "COVID-19" para especificarlo. […] Con respecto al género del artículo, lo preferible es emplear el femenino, [ya que] el género femenino se toma del sustantivo "enfermedad" […] No obstante, el uso del masculino no se considera incorrecto […] Es frecuente el uso de la forma acortada "COVID" (o "covid"), que ya recoge el Diccionario de la lengua española.  2, record 5, Spanish, - COVID%2D19

Record 6,  Textual support,  English

Record number: 6, Textual support number: 1 OBS

SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.  2, record 6, English, - COVID%2D19%20After%20Care%20Sheet%20%2D%20Moderna%20COVID%2D19%20Vaccine%20%28mRNA%2D1273%20SARS%2DCoV%2D2%20vaccine%29

Record number: 6, Textual support number: 2 OBS

COVID-19 After Care Sheet - Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2 vaccine): Annex C found in the Directive on COVID-19 Vaccination (6636-81).  2, record 6, English, - COVID%2D19%20After%20Care%20Sheet%20%2D%20Moderna%20COVID%2D19%20Vaccine%20%28mRNA%2D1273%20SARS%2DCoV%2D2%20vaccine%29

Record number: 6, Textual support number: 3 OBS

COVID-19 After Care Sheet - Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2 vaccine): designation to be used by the Department of National Defence and the Canadian Forces.  2, record 6, English, - COVID%2D19%20After%20Care%20Sheet%20%2D%20Moderna%20COVID%2D19%20Vaccine%20%28mRNA%2D1273%20SARS%2DCoV%2D2%20vaccine%29

Record 6,  Textual support,  French

Record number: 6, Textual support number: 1 OBS

SARS-CoV-2 : coronavirus du syndrome respiratoire aigu sévère 2.  2, record 6, French, - Fiche%20de%20soins%20apr%C3%A8s%20le%20vaccin%20contre%20la%20COVID%2D19%2DVaccin%20contre%20la%20COVID%2D19%20de%20Moderna%28vaccin%20mRNA%2D1273%20SARS%2DCoV%2D2%29

Record number: 6, Textual support number: 2 OBS

Fiche de soins après le vaccin contre la COVID-19-Vaccin contre la COVID-19 de Moderna(vaccin mRNA-1273 SARS-CoV-2) : Annexe C figurant dans la directive sur la vaccination COVID-19(6636-81).  2, record 6, French, - Fiche%20de%20soins%20apr%C3%A8s%20le%20vaccin%20contre%20la%20COVID%2D19%2DVaccin%20contre%20la%20COVID%2D19%20de%20Moderna%28vaccin%20mRNA%2D1273%20SARS%2DCoV%2D2%29

Record number: 6, Textual support number: 3 OBS

Fiche de soins après le vaccin contre la COVID-19-Vaccin contre la COVID-19 de Moderna(vaccin mRNA-1273 SARS-CoV-2) : désignation d’usage obligatoire au ministère de la Défense nationale et dans les Forces canadiennes.  2, record 6, French, - Fiche%20de%20soins%20apr%C3%A8s%20le%20vaccin%20contre%20la%20COVID%2D19%2DVaccin%20contre%20la%20COVID%2D19%20de%20Moderna%28vaccin%20mRNA%2D1273%20SARS%2DCoV%2D2%29

Record 6,  Textual support,  Spanish